The pharmaceutical landscape for blood sugar is changing, and transdermal GLP-1 delivery systems represent a promising development. Unlike subcutaneous injections, this method offers a more convenient way to https://nicolasosqw493878.idblogmaker.com/39747246/glp-1-patches-a-new-approach-to-diabetes-treatment